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INTRODUCTION 
A REVIEW OF THE HISTORY OF BLOOD GROUPS 
At the beginning of the twentieth century there 
developed a problem which was at first unnoticed and 
unencouraged, and originally of purely theoretical 
interest. 'fhis the blood group problem, first demonstra-
ted its practical importance to the question ot blood 
transf11sions and other phases of clinical. medicine,. lat.er 
in the fields of legal,medicine, genetic~, eugenics, 
physiology, immunology, and anthropology. 
During the nineteenth century many men tried trans-
fusing sheep and other domestic animal blood into 
human beings, but with poor results. The number of 
l.atal1t1• ca•sed scientists to investigate this 
problem. The subsequent experiments showed many things 
s11ch as: the erythrocytes ot animals ot d1rterent species 
vary in morphology; that hemolysis or agglutination ot 
the red blood cells oeeur it h11man blood 1s mixed with 
animal blood; that animals could be iDIJllunized with blood 
or ser11Dl or other animals. These observations led to 
the theory of species specificity or the blood. (60) 
Prompted by this theory, Landsteiner in 1900 
investigated the q11est1on or whether or not there were 
speo1f ic blood differences in individuals of the 
same speoies. He noted in his experiments that mixing 
the serum or one individual with the cells of another, 
marked agglutination occurred in some cases, while 
in others the blood cells were unaffected. (60} 
On the basis of his results, he was able to divide 
human beings into three distinct groups. The fourth and 
rarest group was discovered by von Deca.stello and Sturli 
in 1902. (54) 
Landsteiner postulated from his results that there 
exist two specific iso-agglutinogens in the red blood 
cells, and that there exists two specific iso-
agglutin1ns in the serum. The agglutinogens could 
appear together in a blood, or either one could appear 
singly. Furthermore, that these elements were reciprocal, 
that the presence of an agglutinogen in the blood preclu-
ded the presence of the corresponding agglutinin, and 
the absence of an agglutinogen implied the presence of 
the corresponding agglutinin. (54) 
After these blood group experiments were confirmed, 
Jansky in 1907 made the first definite classification 
of the four groups. Moss in 1910 devised another classi-
fication. Finally, the international nomenclature was 
adopted by the Health Com~1ittee of the League of 
Nations; it is universally accepted at the present time. 
By use of the latter olassitication, escaping the 
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confusion ot the others, many mistakes of blood 
grouping and its consequences were avoided. 
Levine and Katzin made a survey of the classi-
fications in use in American hospitals. Their data shows 
an increase in the use ot the InternationRl Nomenclature. 
The interest in the med1o legal applications will 
even stimulate more general use of it because heredity 
of the blood is presented more clearly this way. (51) 
Very little attention was paid to all this work 
on blood groups before the first World War. Conse-
quently, many transfusion reactions occurred. During 
the war the necessity for large numbers of transfusions 
brought the subject into its true light. The use of 
donors with compatible blood resulted in successful 
transfusions for the most r1art. Transfusion became, 
then, the first real application of blood grouping. (54) 
After Landsteiner's discovery a continuation of 
his studies in man and other animals showed that there 
is a marked individuality of the blood of higher 
animals, for instance, in apes, monkeys, dogs, cats, 
horses, pigs, rabbits, birds, etc. The constitutional 
nature of the blood groups in man and animals was 
obvious, because ot the constancy of the groups. The 
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constitutional nature of the individual differences of 
blood hns been emphasized by the discovery that the 
substances which characterize the four groups are 
present in practically every tissue of the body and 
have even been found in soluble form in serum, saliva, 
semen and urine. Their nature is emphasized further 
by the fact that they are determined solely by heredity 
and are not influenced by environment. (60) 
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THE UNCOMMON BLOOD GROUPS 
While attempting to find further differences 
in the blood, Landsteiner and Levine (18) showed that 
there exists a number of individual differences of human 
blood, and that it is possible that these are due to 
variations in substances rather than proteins. 
Biochemically, there are two theories in regard to 
the explanation of the differences of human blood. (18) 
1) The thought has been expressed that variations in 
proteins are the basis for the differences exhibited by 
individuals of a species. To substantiate this view 
are the enormous numbers of proteins resulting from the 
)ossible combinations of amino-acid.a. There has been 
no experimental evidence for this hypothesis, however. 
2) Different 1e the view suggested by some that it is 
probeble that the blood Antigens contain specific non-pro-
tein substs.nces--possibly of a lipoid na.ture. Land-
steiner (15) showed that alcoholic extracts of blood ex-
hibited group specificity--this seems to substantiate the 
idea that proteins are not responsible for individual 
varieties shown by serological reactions. It is conceiv-
P.ble, on the other hand, that a particular protein may 
be a constant characteristic of a species. 
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Antibodies, being a special type of protein, 
cannot be considered an~logous to those forming the bafis 
of species specificity, which is inherent to all sorts 
of proteins, such as hemoglobin, albumin, globulin, etc., 
aside from a few apparent exceptions. 
The Subgroups of A and AB 
In 1911 von DYngern and Hirszfeld found that the 
blood group A was not homogenous. (5) They absorbed 
the serum of a person of group B and the red cells of a 
person of blood group A. and noted that the absorbed serum 
was able to clump the red blood cells of the majority of 
persons of group A, although it failed to clump the cells 
of some. This observation was confirmed and finally led 
to a division of group A into two subgroups, A1 and A2 
and of group AB into A1B and A?J3. 
The phenomena described can also be produced with 
group 0 serum and is apparently caused by the existence 
of two agglutinins, a and a1 • The agglutinin,a,acts on 
all A and AB bloods, the agglutinin, 8i' acting on only 
the majority of A and AB bloods, mainly those of A1 and 
A1B. Bbods not reacting with the absorbed group 0 or group 
B sera belong to the subgroup A
2 
and A2B. Group 0 and 




_J.a.tun of the Subgroups: 
Wiener (58) was the first to report a case of 
1so-immunization to the A1 agglutinogen. This brings 
forward the old question of the nature of the differences 
between the subgroups. It becomes a very difficult 
problem to understand whether the difference is 
quantitative rather than qualitative. 
It is generally acknowledged that the serum contains 
two qualitatively different aggl•tinins, namely, a and 
a.1 • In regard to the cells, the reactions have been ex-




Lattes and Cavazutte (29) consider the difference 
between the subgroups merely quantitative; that is, to 
be caused by varying a.mounts of the same agglutinogen. 
Landsteiner and Witt (28) offered evidence in 
their experiments that there are two agglutinins, a 
and a1 , and from this assumed the existence of agglutino-
gena A1 and A2• 
Landsteiner and Levine (19) offered further evi-
dence for qualitative differences in the subgroups 
with their experiments on atypical agglutinins. 
{See page 20. ) 
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The agglutinins, a and a1 , are related to the 
11 cold agglutinins", described by Landsteiner e.nd Levine 
in 1926. (28) The latter agglutinins dPrive their name 
from the fact that they differ from ordinEcry iso-
agglutinins, in that their effect, generally, is much 
diminished by increased temperature; that is, they 
are much more active at 20° C. then at body temperature. 
The "cold " agglutinins described by these men were a 
e.nd a
1 
end Alb; they may even react at body tempere.ture, 
which may account for some subgro~p incompAtibilities.(5) 
The "cold" agglutinins are generally of two types, 
one non-snecific (e.utoc:gglutinins) and specific, the 
letter being related to the atypical agglutinins. (60) 
These, in turn, are generei.lly of two types, one related 
to subgrou0s of A and the other is non-specific. These 
anomalous iso-agglutinins in the serum does not in any 
way interfere with the determination of the group of 
cells, since the erythrocytes give typice.l reactions 
with typing ser&. {60) 
The a2 agglutinin is really an agglutinin directed 
specifically to blood group O; it acts on A2 cells only 
because they are heterozygous and contain the factor O. 
This explanation ( 55) does not a.ffect the arguments for 
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a qualitative difference between the agglutinogene A1 
end A2 . ba.eed u:i)on reactions with a· and ~ agglutinins. 
Differentiation of the Subgroups in the Newborn: 
The majority of newborn children hRVe no detectable 
iso-agglutinins 1n their blood. ( 15) These usm,lly a.ppear 
during the first year of life and the titer rises gradu-
ally, until a peak is reached during adolesence. Later, 
a slow decline takes place, which continues through 
life. Davideohn (5) thinks the agglutinogens are well 
established at birth, while Wiener (6J) states that the 
agglutinogens have not reached their full develo,1ment at 
birth. For this reason, determination of any of the 
subgroups of A or AB is not reliable for the blood of 
an infe.nt. 
The Significance ot the Subgroups--The1r Role in 
Transfusions: 
Generally, when blood of the subgroups of A and AB 
are transfused, no reaction of any sort oceurs. In 
certain rare individuals, however, the body recognizes 
the distinction between the subgroups and finds the 
blood of the heterologous subgroups as foreign. In 
such individuals, with preformed irregular 1so-ant1bodies, 
transfusions of the subgroups may be followed by a mild 
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or no reaction whetsoever. There would be a production 
of more potent immune iso-agglutinins, so tha_t sub-
sequent transfusions of blood of an incompatible 
subgroup may lead to a severe or fa.tel reaction. ( 58) 
The chances that the subgroups will c2use reactions 
are not very great for gwo reasons: 1) The greater major-
ity of bloods of groups A and AB do not con te_in either 




; 2) The 
irregulHr 1so-R.gglut1n1ns, when present at all, are of 
such low potency, being active only at low temperatures, 
in contr1=1st to a .c<nd b e.gglut1n1ns, which are present 
~t 3?0 c. (58, 64) 
Two rules must be followed in order to ascribe 
tr2nsfusion reactions to the subgroups. These are: 
1) It is necessa.ry to show the.t the donor patient be-
long to different subgroups; 2)The patients serum must 
contain a1 or a2 agglutinins, rather than some other 
1soan ti body, such as the Rh fa.ctor. ( 58) 
It is know that when blood of an incompatible 
blood grou) 1s transfused, a serious or even fatal 
hemolytic reaction may result, expecially in patients 
whose sera contains potent nPtural iso-agglutinins. 
Transfusions of blood which is incompatible may, 
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in excPpt1onal instances, give rise to only mild symptoms--
or none at all. In these patients the natural iso-aggl~­
inins are probably of very low titer. (58) 
No pet1ent receiving incompatible blood ever derives 
full benefit from the transfusion becausQ the blood is 
~~u1ckly hemolyzed and eliminated. (69) 
Just after such transfusions have taken place it is 
noted that there may be a drop in the !so-agglutinin 
titer, due to the absorption of the 1so-agglut1nins 
by the transfused incompatible cells. This is generally 
followed by a rise in titer, far exceeding the original 
level--due to the production of immune !so-antibodies in 
resoonse to the introduction of foreign body cells. A 
second transfusion of incompatible blood a.t the high 
titer level would probably give rise to a severe or fatal 
regction. (58) 
Observations made on patients, unintentionally, 
indicFte that the properties A and B are antigenic for 
individuals whose blood lacks the corresponding agglutinin. 
As for the antigenicity of the subgroups of A Rnd AB1 , 
there has never been any systematic study on this 
question as yet. {58) Only one case (?3) has ever been 
reported of iso-immuniza tion of a.n A1 individual to 
(11) 
A2 blood. If tbe theory is correct that the ca:oa.c i ty 
to immunize against the subgroups is restri2ted en-
tirely to those individuals with corr·e spondir,g pre-
formed irregular iso-agglutinins, then these eases must 
be re.rer than immunization r'galnst A1 blood. 
As stated before, agglutinin a 9 is very rare and 
i.-' 
seems to be of a Jifferent nature t~Rn a
1
, because 
it clumps red cells of group 0 in addition to those 
of A2 and tte ~gglutin· tion is usually more pronounced. 
The proportion of persons with a1 agglutinin is 
larger in the subgroup A2B than in the subgroup A?.(5) 
One can see the risk involved in the old idec; that 
cross-matching is not necessary in universal recipients. 
Davidsohn (5) states that it should apply only to 
persons of subgroup A
1
B whose blood is free of a2 




The danger of tr~·nsfusion reac t1ons by the sub-
groups is not limited to incompatibilities, but also 
failures to recognize subgrou9 A2 • Typing serP of 
low titers are usually recuonsible; that is, a weak 
agglutinating serum which fails to clump the weak 
red celJ s. The serum may beh:=,ve e~«9ctly like the serum 
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of group O, and the dangers of the use of such a donor 
can easily be seen. 
A survey by Levine and Katzin (.~2) showed that 
such a practice is still common--that donors selected 
on the baEis of blood grouping alone, ithout regard to 
cross-matching, pa.rticule.rly in reference to universal 
donors. Cross-matching, however, may fail to show the 
true A
2 
nature of the donors subgroup because of the 
low titer of iso-agglutinine in the blood of some 
patients. 
There is d~i.nger of a reection when a false uni-
versal donor { e.ctually group A2 ) is used for a .Ja.tient 
of subgroup A1B, on account of the possible, though very 
rare, presence of the agglutinin a 2 in the serum of people 
of subgroup A1B. Tl-. ere is also a h8 z··rd in the use of 
a true universal donor for a recipient of subgroup A1B 
with agglutinin a 2 , the latter reacting with cells of 
group 0 even more readily the.n with the cells of 
group A2 • An actual case of iso-immunization of an 
A B ind1v1duel by transfusion using group 0 blood has 
1 
been reported by Wiener, Hyman, and Or.emland, and 
Samwick. ( 66) 
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There exists a danger of a reaction between rare 
a2c'glutinin [~ 2 and cells of subgroup A2 and group 0, 
when a true universRl donor or an A2 donor is mistaken 
for a donor of group o, and 1s used for a recipient of 
A1 with rBre agglutinin a,._. ~' 
(5) 
Ye can see that since so many patients of group A 
have been tr nsfused with blood from group A donors selec-
ted at random, that it indicates the antigenic activity 
for tt.ese subgroups must be weak. Just the fa.ct that 
there is an 1ntragroup A reaction does not meen that 
the subgroups are to blame. (58) 
In Wiener's and Peter's (67) report of their 
experience with over 3,000 trensfusions, the evidence 
of even minor reactions among patients of group A, when 
donors are chosen without regard to subgroups, was not 
more frequent than among pRtients in group O end B. In 
fact, cases of iso-irnmun1zat1on against subgroups of A 
are probPbly rarer than with the property Rh. Others 
have related such experiences. '.Veiner ( 58) concludes that 
the majority of 1ntragroup reactions are due to some 
blood factor other than the subgroups. He suggests that 
some rare constitutional anomaly may be required to pro-
duce immune a.1 and e_ 2 iso-antibodies. Possibly A 
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agglutinogen is poorly developed or perhaps the serum 
contains weak irregular a1 and a2 iso-agglutinins 
from the ,eginning. 
In view of these findings, then, it is safe to 
disregard the subgroups when selecting donors for 
transfusions, except in those rare cases when agglutinins 
a1 or a 2 are found. In that case the blood of the 
homologous group should be used. (67) These agglutinins 
can be de tected by cross matching. 
Recognition .2! the Subgroups: 
Since most of the reports in related literature 
suggest that in the greatest number of cases the errors 
are due to the use of typing sera with low titers of 
iso-agglutinins, it follows that it is imperative that 
high titered sera are used in testing !or the subgroups. 
Davidsohn (5) outlines in a detail a method for 
the recognition of the subgroups. He uses a highly 
specific rabbit immune serum, which is highly titered 
and easily produced. A proper dilution of this serum, 
as determined by titration, makes it possible to 
.. 
differentiate the s~bgroups within five to ten minutes. 
Wiener (6?) suggests the folllwing method of 
cross-matching, as it will anticipate most 1ntra group 
hemolytic re~ctione: 
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1) Two drops of the patient's serum separated 
from the clot at refrigere.tor temperature, plus one 
drop of donor's cells, suspended in a test tube. 
2) The secnnd tube contrins a similar mixture of 
the patient's serum and the patient's cells. 
These tubes are plRced in ice water for five 
minute8, then centrifuged while cold. The reactions 
are reed grossly and microscoyioally. If there is 
no reaction the donor is compatible. If both tubes show 
a. reaction, it is prob::~bly an auto-agglutinin and the 
donor may be used. 
Heredity .2f ~ Subgroups: 
Landsteiner and Levine (17) made the first studies 
on the heredity of the subgroups. Later Friedenreich 
lmd Worsaae proposed a theory of the heredity of the 
subgroups. The theory states that there exists four 
allelomorphic genes ~' A2 , B and R (absence of agglu-
tinogens) with genes A1 , A2 , and B dominant over R, 
and A1 dominant over A2 . (60) It is suffice to say 
here that instances of exceptions to this theory have 
been reporte0. (17) 
The folllwi~g rules should hold if this theory is 
correct: (60) 
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1) The agglutinogen A1 cannot appear in the blood 
of a child unless present in the blood of one or both 
parents. This rule depends on the dominance of Ai over 
2) An A1B parent cannot have an A2 child and vice 
versa. 
3) Children of subgroup Ar;f3 cannot result from 
the matings A1BxB and A1BxA1B, unless the other parent 
supplies gene A2 • 
4) In the matings A1xO, A1x~, AixB, AfAiB, and 
A1xA2B, if one child belongs to either group O or B, 
none of the remaining children can belong to subgroup 
A2 or A';f3 and conversely. 
Studies on the heredity of the subgroups have 
been scant. The studies performed so tar, indicate 
that the above theory is fundamentally correct. 
Agglut1nogen ,!3: 
Wiener (60) reports that Fischer and Hahn, 1n 1975, 
and Friedenreioh, in 1936, reported independently the 
occurrence of persons of group A whose blood gave very 
feeble reactions with the most potent anti A sera. 




• This discovery gives rise to two 
more subgroups--nGmely, A3 and A3B. Friedenreich even 
thinks there are additional subgroups of group A. 
Further experiments show that these newer sub-
groups contain agglutinin b as in ordinary group A 
sera, and in addition may cont.:,in 8?• "cold agglutinin", 
as om A2 or A2B sera. Studies show that the occur-
rence of property A3 and A3B is determined by heredity; 
and as Friedenreich (60) points out, the gene A3 is 
recessive to genes A1 and A2 , but dominant over gene R. 
Its practical importance, as we can see, lies in 
the fa.ct that because of its pro9erties, it might be 
eRsily missed, leading to errors in the typing of blood. 
Prood of' a fourth al lelomorl1hic gene, r1.4 , has re-
cently been reported by Gammelgaard and Marcussen. Its 
importence is similar to agglutinogen A3 • (?3} 
The Subgroups of Group B 
After many unsuccessful experiments by noted 
scientists in attempt to demonstrate the existence of 
subgroups of group B, Friedenreich has shown that the 
human B agglutinogen shows seve:ral distinct serological 
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properties, (60) designated by him as B1 , B2 , and B3
. 
It has since been found by him that B2 and B3 are also 
present in the bloods of lower animals. 
Investigations on this subject and on agglutinins 
analogous to a1 and a2 have not as yet reached the 
stage where practical application is possible. 
The Agglutinogens M and N 
Since Landsteiner, 1n 1900, made his important 
discovery of blood groups, there have been many attempa 
made to discover further differences in human blood, in 
addition to group distinotion. Observations on individu-
al differences of human blood, aside from the tour 
blood groups, indicated that the bloods of individuals 
is not identical biochemically, even though it belongs 
to the same group. (l?,a) 
Instances had been reported by Lindemann (40) 
and others, in which the first transfusion with a 
compatible donor was followed by severe symptoms. There 
were only casual remarks about the occurrence of atypical 
iso-ant1bodies. 
Landsteiner and Levine (17,a) reported the finding 
of two cases in which they found atypical agglutinins. 
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Landsteiner and Levine, in 192?, while working 
on this problem, (17, 16) described the finding of 
differences of human blood based on the use of immune 
agglutinins. They reported a sharp differentiation of 
human bloods within the common blood groups, found by 
absorbing a number of anti-human blood immune sera 
from rabbits with blood corpuscles of certain individuals 
regardless of group. Two of the factors demonstrable by 
these sera were designated as M and N. 
These men found that three distinct types of human 
blood could be distinguished, type M (the bloods 
possessing M, but lacking N}, N (the bloods possessing N, 
but lacking M), and MN (the bloods possessing both M 
and N). Not a single blood lacking both agglutinogens 
was found. It was also found that the distribution of 
these types was the same in each of the four blood 
groups, so that the agglutinogens M and N are unrelated 
to the agglutinogens, A and B. These differences point 
to the fact that there is a high degree of biochemical 
differentiation among individuals. 
Fr1edenreich in 1936 (60) reported the existence 
of oertain rare 1nd1v1duals of type MN whose blood 
reacts we$kly with anti-N fluids. This factor was 
-20-
designated by him as N2• Blood containing N2 alone 
has not as yet been reported. 
Hered1 ty .. 2...f ..!. and N: 
The first report on the heredity of the agglutinogens 
M and N was made by Landsteiner and Levine in 1928. (20) 
These authors succeeded in demonstrating that M and N 
are inherited as mendelian dominants and that their 
heredity depends upon a single pair of allelomorphic 
genes, M and N. (17a) 
According to this theory, only three genotypes 
are possible, MM, MN, and NN. According to this theory, 
then, two ru~es should hold as true: l} Agglut1nogen M 
cannot appear in the blood of a child unless present 
in the blood of one or both parents. This rule should 
also hold for agglutinogen N. 2) A type M parent cannot 
give rise to a type N child--a type N parent cannot give 
rise to a type M child. (60} Exceptions to these rules 
have been reported, however. (61,62) 
Additional data shows that there is a higher incid-
ence of the factor M among colored than white individuals. 
(47) It has also been found that the distribution of 
the two types is independent of sex, since the 
frequency in both sexes is the same. These types have 
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been shown not to be sex-linked. Landsteiner and 
Levine (17) have shown that the distribution of the 
factors M and N is not different in the four blood 
groups, so that no correlation exists between these 
two sets. In addition, Wiener (63) confirms the re-
port of these two men, that agglutinogens Mand N 
are probably inherited independently of agglutinogens 
A e.nd B. 
Development of ~ and !: 
Moureau (60), according to Wiener, has been able to 
demonstrate the presence of the agglutinogens M and N in 
human fetuses as early as the second month of intra-
uterine life. It has also been definitely shown that 
these agglutinogens can definitely be demonstrated at birth. 
However, no thorough studies on this subject hAve, as yet, 
appeared in the llterature. 
Other Differences ot Human Blood 
Demonstrable by Anµial Sera 
Agglutinogen f: 
At the time Landsteiner and Levine (16) described 
the M end N agglutinogens, they briefly described 
another property also demonstrable by immune rabbit 
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serum e.nd obtained, with some d1ff1cul ty. this 
property which they called P. Such immune sera were 
found to give reactions similar to those of certain 
extre.-agglutinins in human sera and of certain animal 
ser~'. From this it was concluded (':,;) that the 
properity P represented a group of related agglutinogens 
and was not a single entity. 
With regard to the relationship of agglutinogen P 
to transfusions, Wiener (67) knows of only one case 
where the injection of blood containing agglutinogen P 
v.·as giv,-n to an individual lacking the agglutinogen 
resulting in stimulating the formation of P iso-
antibodies. The patient accordingly could use only 
blood of the correct group P. 
As for the heredity of the agglutinogen P, 
Landsteiner and Levine (23) have shown that this factor 
we.s inherited. Zieve, Wiener, and Fries (72) have 
shown that this factor is not sex-linked or linked with 
agglutinogens A-B, M-N in its heredity. Dahr (60) 
investigated this problem and found that P is inherited 
as a simple mendelian dominant. 
Agglutinogen Q: 
Wiener states that two Japanese, Furuhata and 
Imamura, have described an agglutinogen,Q, which tpey 
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detected with an absorbed normal pig serum. •his 
property seems to be a correlation between the 
renctions for P and Q., and is different from any of 
the agglutinogens, A, B, M, and N. 
Wiener, in his own work, found that agglutinogen :,1 
was similar to agglutinogen P, (60) in that it was 
found much more frequently in negro than in white blood, 
/'(nd the.t strong reactions f9r Q. gave strong reections 
for P and weak reactions for Q ga.ve wea.k reActions for P. 
He concluded that agglutinogen ~ belonged to the group 
of agglutinogens designPted Rs P by Landsteiner and 
Levine. ( 16) 
Additional Differences: 
Weiner (60) states that Andresen desc1~1bed a new 
agglut1nable property found with human (OM) immune 
rabbit serum. He found that 45% of human beings had 
this agglutinogen. 
Landsteiner, Stratton, and Chase (24) obtained 
an immune rabbit serum from the injection of negro 
P blood. This serum, after at>sorpt1·:n, gave reactions 
for a new agglut1nogen. They found that is very 
rare and that all the bloods giving positive reactions 
belonged to types N or MN. 
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Using normal sheep immune serum, Schiff ( 1 0) 
described a new agglutinogen, H, which he found to 
be inherited as a simple mendelian dominant. 
Using normal eel serum, SugishitA (60) de-
scribed those human bloods which are agglutinated by 
higher dilutions of e~l serum as type E. Those bloods 
P.gglutin2ted with undiluted eel serum, he designated 
as e. Sugishita described these agglutinogens as 
hereditary qualitles. 
Differences of Human Blood Demonstrable 
by Human Sera 
As pointed out previously, a small percentage of 
normal human sera, in addition to the common iso-
agglutinins, contains "anomalous" agglutinins that 
produce reactions of a lesser degree. Instances of 
these agglutinins have been reported ever since the blood 
groups were first described, but they were not studied 
systematically. 
Several times sera containing these anomalous 
agglutinins were discovered bec:ouse they geve rise 
to tra.nsfusion reactions. Thus, Ottengerg and Johnson 
(49) discovered a rather active anomalous agglutinin 
when a.n attempt was made to discover the reason for a.n 
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unexpected transfusion reaction. This agglutinin was 
found in an individual of group B and was found to be 
active at 37°0. 
Culbertson and Ratcliffe (4) reported an intra-
group transfusion ree.ction which they explained by an 
anomalous agglutinin--acting on 90~ of all blood groups. 
This serum could be used to detect the presence or 
absence of e particular agglutinogen in human blood. 
This agglutinogen was found to be similar to the 
agglutinogen X. 
Landsteiner and Levine (?l) investigated the 
problem of anomalous agglutinins and found that the 
most frequent of these were related to the subgroups 
of A and AB. One other which they found was similar 
to tbe extra-agglutinin, 1, whose reactions correspon-
ded to immune anti-P sera. Reactions of other sera 
could not be classified. 
Nigg (46), in studies on the extra-agglutinin, 1, 
concluded. that it was inherited indepen<lently as a 
mendelian dominant. 
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THE Rh FACTOR 
It was only unt11 recent-y that dangers inherent in 
blood transfusions have received proper emphasis. Earlier 
li tere.ture contRins many reports of reections as a result 
of such things as errors in typing, failure to cross-
match or other poor techniques. As methods did improve 
and as the number of reactions dropµed, more transfusions 
were given. (9) The frequent use of transfusions offered 
scientists an o ~port unity to study the ~:irobl em of the 
effect of immunization of humnn beings with the blood 
of other human beings. (60) 
Landsteiner and Levine (23) were among the first to 
report a case in which immune iso-a.gglutinins were 
formed following repe2ted transfusions. RecEc':tly, how-
ever, reports have appeared in the literature discussing 
intragroup reactions, even with the most careful tech-
nique. 
Culbertson and Ratcliffe (4), in 1936, called 
attention to two group D patients in their puerper1um with 
atypical agglutinins in their s~rum--no significance was 
attached to it. Also,in the same year, Zacho reported a 
case of a woman with a premature separation of the 
placenta. (34) The transfusions glven resulted in an 
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accident which he attributed to atypical agglutinins 
active on the donors cells. He found that this ag-
glutinin had the property of greater activity at 
3?0 c than at lower temperatures. 
Neter (45) reported a case of an intragroup trans-
fusion accident which revealed the presence of an ab-
normal iso-agglutinin. He noted that this agglutinin 
was only temporary in character and gave its strong-
est reaction at warm temperi=ttures. 
Levine and Stetson (38),in 1939, reuorted a case 
of a very severe transfusion accident occurring in a 
woman who had jut=t delivered a stillborn fetus. This 
accident followed transfusions of apparently com~atible 
blood. They found that the reactions were independent 
of the M. N. or P blood factors, and that the agglutinin 
found in the patient's serum was very temporary in 
character. Their explane.tion of ttie case was based 
on the as·umption that the petient wa.s immunized by an 
antigen from the dead fetus when 1t we,s still in utero. 
'l'his antigen, it was assumed, ·;;as inherited by the 
fetus from the father. 
Still more similar cases were reported (8,32,34) 
and the basic cause remained unexplaineble until after 
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the experiments of Landsteiner and Wiener in 1940. 
The evidence presented in these cases could not be 
eX})la,inerl. by the subgroups of A or AB beceuse their 
properties wer'"" such that they were "cold agglutinins 11 , 
that 1s their strongest reaction was at lower tem-
perRtures, and they were not of a temporary nature. 
Not only that, but the reactions were found to be 
independent B.lso of M, N, and P blood factors. 
Observations made with immune sera, and espeoi-
ally from the evidence provided by test::, v:ith occas-
ionally occurring normal and post-transfusion sera contain-
ing irregular agglutinins, one may conclude that there 
are still many individual properties of human blood 
that are not demonstrable by ordinary technique. There 
have been many attempts made to discover other ag.i'lutino-
gens by the technique used by Landsteiner and Levine, for 
finding M, N, and P--that is, by using immune sera pre-
pared by immun'iz1ng rabbi ts against human blood. (16) 
These results turned out so poorly that the experiments 
were given up. (24) 
Consequently, other ways of approaching the problem 
were tried. One way was by immunizing laboratory 
animals with other animals blood--think1ng that ''1erhaps 
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animal blood contained antigens related to agglutinogens 
in huma.n blood. One result that favored this idel'l was 
the experiment by Wiener and Landsteiner, in 193?, 
where they showed that ct:rtain anti-rhesus immune serP 
contRined agglutinins specific for human agglutinogen M. 
( 25) 
Pursuing this idea, these two men, in 1940, found 
an individual property of human blood , which they detec-
ted by using rabbit immune sera, produced with the 
blood of the Macacus rhesus monkey, with selected 
human bloods. This factor, different than any of the 
other known agglutinogens, was designated by them as 
Rh. ( 26) 
The Rh Factor and Its Relation to Transfusions 
Evidence of clinical importance of the Rh f'actor 
was first obtained by ,1ener and Peters {67), when they 
came into possession of some blood from patients who 
had just shown hemolytic reactions after receiving repea-
ted transfusions of blood of the proper group. They had 
noted that the greatest majority of intra group reactions 
ever recorded occurred with intra or oost-partum pRtients. 
In one of their cases they explained the hemolytic 
reaction in this way: The patient having group 0 
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(Rh negative} blood and an apparently weak anti Rh 
hemolysin 1n his serum was transfused with Rh positive 
blood of the same group. Repeated transfusions served 
to stimulate the production of anti-Rh antibodies of 
higher titer. Accordingly, a later transfusion of 
Rh positive blood gave r1se to an acute hemolytic 
reaction. 
Some months later than this report, Levine and 
Katzin (34) reported several cases from which data was 
available. In one case, a post-partum patient was trans-
fused with blood from her husband. A reaction occurred, 
which they found WB.s caused by atypical agglutinins in 
the woman's serum acting on the cells of the husband. 
This tended to support the hypothesis of Levine and 
Stetson (38) that under certain conditions, the mother 
may be immunized by the fetus or fetal parts of the 
placenta. They called particular attention to the 
similarity of this agglutinin to the anti-Rh of 
Landsteiner and Wiener. (26} 
Levine, Katzin, and Burnham (35) then reported 
several cases in which the 1:tgglutinine found exhibited 
a specificity different from that of anti M, N, or P. 
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These agglutinins were shown to run parallel to the 
anti-Rh of Landsteiner and Wiener. (26) Tests done by 
these men confirmed the report of sensitivity of 
of these agglutinins at 37°0. Consequently, they were 
called "warm agglutinins" to differentiate them from 
other atypical ones. They again called attention to the 
hypothesis of Levine and Stetson (38) as a probable 
explanation of the origin of these agglutinins. 
Levine and Polayes (37) reported an intra-group 
reaction in a patient in her puerperium. She had never 
been previously transfused. They again used Levine and 
Stetson's hypothesis (38) for an explanation of the 
reaction. 
Scott and Conant (52) reported an intra-group 
reaction occurring after reoeated transfusions. They 
proved this reaction to be due to the formation of 
anti-Rh agglutinins in the patient's serum, so that 
subsequent transfusions gave rise to a reaction. 
All of these cases and subsequent findings raise 
the question of why these reactions a.re not encountered 
more often. Wiener and Peters (67) explain it by the theory 
that not all Rh individuals are cap;:ible of producing Rh 
antibodies. Some special constitutional factor may be 
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required, possibly the presence of preformed antibodies. 
Also that the interval between the transfusions must be 
long enough to permit an adequate rise in the titer of 
the antibody. 
It is probe.ble that the anti-Rh agglutinins are 
responsible for about 90% of all intra-group transfusing, 
accompanied by adverse results, or in pregnancy at the 
first transfusion. In short, it means that certain 
Rh negative individuals can produce anti-Rh agglutinins 
either by immunization with the Rh factor of the fetus 
or by iso-immun1zat1on with Rh positive donors of the same 
group. 
That the property Rh is a true antigen is established 
by its ability to produce immune antibodies. (6?) 
!so-antibodies for Rh do not occur normally in human 
plasma, and the transfusion of blood containing Rh into 
patients whose blood does not have iso-antibodies for 
this agglutinogen, is uneventful ordinarily (58), the 
transfused cells surviving in the patient's circulation 
for periods un to three to four months. (68) 
However, for the certain percentage of patients who 
do not have the Rh f'a.ctor, only blood that is free from 
Rh is suitablP for transfusion. In case Rh positive 
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blood is injected into patients whose blood is Rh 
negative, the body recognizes it as foreign a.nd tries to 
eliminRte it. The first transfusion shows gradual hemo-
lysi::::, so that there are no visible symntoms. This hemo-
lysis, however, is followed by the appearance of Rh 
iso-antibodies and subsequent transfusions of Rh positive 
blood may result in a fe.tal or severe reaction. ( 67) 
The Rh Factor and Erythroblastosis Fetalis 
Shortly after Levine and Stetson (38), in 1939, 
stated their hypothesis of 1so-immunizat1on, Burnham, 
Levine and Katzin (35) associated intra-group trans-
fusion accidents with the etiology of erythroblastosis 
fetalis. Shortly after this, Landsteiner and Wiener (27) 
in 1941 were the first to report that the agglutinogen 
Rh WRs responsible for the severol manifestations of 
this disease. 
It is interesting to note here the countless 
artic-es and the many theories that have been written 
in connection with erythroblastosis fet~lis. The mani-
festations of this disease, icterus gravis neonatorum, 
hydrops fetalis, and congenital anemia, were at first 
considered different entities, until after much research 
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had been accomplished, authors,genere.lly, began to find 
similarities in the underlying 9athology (11, 42,6) of 
these conditions. Finally Clifford and Hertig (3) 
concluded that erythroblestosis fetalis is descriptive 
of the seme underlying pathological process. 
In earlier literature, most of the theories as to 
the etiology of this di see se offered inadequate explcma-
t1ons as to the possible causes. The actual concept as 
to the etiology ~as developed from the studies on 
atypical agglutinins which have already been discussed. 
It is of interest to note an article written by 
Ottenberg in 1923 (47) on the etiology of eclamp2ia. 
He expressed his belief the.t the etiology of eclampsia 
lies in the fact that there is probably a. transfusion of 
incompatible blood of the child into the mother's circu-
lation, a.s a result of a. communication through the 
placenta. He also expresses the belief that several other 
unexplained diseases euch as jaundice of the newborn and 
certain cases of hemorrhagic disease of the newborn might 
also be due to accidental placental transfusion of incom-
patible blood from the mother to the fetus. 
Darrow in 1938 (8) concluded., after a long study, 
thAt: 1) The primary influence giving rise to the 
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pathological processes in a series of children with 
erythroblastosis in the same family must be traced to 
the mother; 2) An antigen-antibody reaction seems to 
explain the best, all aspects of the related disorders 
in this disease. 
Levine, Katzin, Burnham (35), in 1941, discussed the 
possible bee.ring of iso-immunizet1on in pregnancy to the 
etiology of erythroblastosis fetalis. They referred to 
a series of seventeen patients in which atypical 
agglutinins could be demonstrated. They presented 
sufficient evidence to show that these atypical 
agglutinins ran parallel to the Rh factor of Landsteiner 
and ~iener. The patients presented histories of 
various obstetrical complications, such as toxemia, 
macerated fetuses, repeated Abortions, miscarriages, 
and three of erythroblastosis. They stated that it is 
probable that there is a connection between the 
occurrence of these complications and the presence of 
immune-agglutinins in the mother. 
This relationship suggested a theoretical b~sis 
for the etiology of erythroblastosis fetalis in some 
c~ses 2nd the hypothesis of iso-immunization could 
readily explain the familial incidence. 
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They assumed, then, that the aty-;:,ical .s.gglut-
inins in the mothers serum were capable to going 
through the plccental b['-rrier so that the e.ntibodies, 
by their continual action on the red blooa cells and 
perhaps feta.l tissue cells, induced erythroblastosis feta-
l is. In the presence of 9 sufficient amount of agglutin-
ins, the fetus may die in utero. (See Levine and Stetson, 
Ref. 38) Similar explanPtions may apply for some still-
births, miscarriages, a.nd abortions; in fact, Burnha."m 
(1) even suggests that the erythroblastosis group be 
broadened to include some of the macerated fetuses 
not due to syph111s, diabetes, or toxemia, and many, 
if not most, of the anemias of the newborn. 
In later work, Levine, Katzin, and Burnham (39) 
considered as true the fact that erythrobli:stosis 
fetalis results from the passage of the mother's immune 
iso-agglutinins through the placenta to act on the sus-
ceptible blood of the child. The immGne iso-.s.gglutinlns 
resulting from immunize.tion of the Rh negative mother by 
Rh positive blood of the fetus. (27) 
According to the theory of iso-immunization, the 
immune ~gglutinin passes through the placenta and 
ex~rts a lytic action on the susceptible fetal blood.(39) 
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This, however, could not occur if the Rh factor had a 
wide distribution throughout the tissue cells and body 
fluids because it would then specifically bind the 
anti-Rh agglutinins. Recent tests (39) show no evi-
dence of the Rh factor in numerous samples of saliva, 
seminal fluid, or sperm cells of an Rn positive 
individual. Tbis then seems to subEtant1ate the theory 
that the Rh factor is limited to the red blood cells. 
However, there should be a comprehensive study of various 
body organs and fluids as Kosjakov and Tribulev (14) 
did with the agglutinogen M and N. 
In erythrobL~ s tosiE, nothing is known of the 
circumstances which permit immunization of an occBsional 
Rh negative mother by an Rh positive baby and not the 
immunization of a vest majority of mothers. Nor can 
occasional ceses be expla.ined in which the anti-Rh 
agglutinin was formed in the mother but caused no 
apparent harm in the be.by. It ce.n be se.id that the 
prevention of erythroblastosis fetalis is still un"-.nown. 
If recognized in time, most be.b1es live long enough to 
be cured by transfusions. (1) 
In a statistical study on the relationship of the 
Rh factor to the pathogenesis of this disease, Levine 
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Vogel, Katzin, and Burnham made the following observa-
tions: (3Sl) Of 111 mothers of infants with erythroblasto-
siE 9% were Rn positive and 90% were Rh negative. Sixty-
six husbands of these mothers were 1007~ Rh positive, 
and 58 affected babies were 100% Rh positive. These 
men assumed, then, that these findings explained the 
incidence of erythroblnstosis in 91% of the families 
studied. Levine and Polayes (3?) have shown that there 
are other blood factors inducing iso-immunizat1on. 
There is considerable evid~nce at the present time 
that the familial nRture of erythroblastos1s fetalis de-
pends on the heredity of the blood factors involved. 
The incidence in certain mothers and the sporadic occur-
rence in others, would seem to be due to the homo or 
heterozygosi ty of the father's blood. ( 37) 
It may be of interest to the rea.d;:;.r to refer to a 
recent case of erythroblastosis fetalis occurring at 
the University of 1~ebraska Hospital. (?) The child died 
after living only two days. Smears were taken of the 
father's mother's and child's bloods by Dr. J.P. 
Tollman. These smears were to Dr. Wiener, who later 
the following information~ Father, group OM, Rh positive; 
Mother, group OM, Rh negative; Child, group OM, Rh 
positive. 
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The Rh Factor and Blood Dyscrasias 
Observations by Wiener (60) supply an explanation 
for conflicting clinical results obtained by different 
clinicians in the treatment of blood dyscrasias or other 
diseeses when repeated trf.lnsfusions are given. She"rpe 
and Davis (53) reported two cases of severe crises in 
hemolytic jaundice in which repeated transfusions 
cPused dangerous reactions. They concluded from their 
experience that transfusions are dangerous in the pre-
sence of severe crises, and are countra-indicated pre-
operative1 y (to spleenectomy). Among other men warning 
against the use of transfusions in hemolytic jaundice 
were Wise (70) and Hartfall and Stewart (10). 
The unsatisfactory results obtained by some invest-
igators can probably be attributed to inapparent 
hemolysis of the donots blood, or to P hemo 1 ytic reaction 
due to the presence of iso-antibodies in the patien~s 
serum, giving reaction~ independent of the blood groups. 
( 58) 
From a series of ten cases, Wiener (58) seems to 
think that the majoritj of such iso-antibodies corres-
pond to the property Rh. The correct use of Rh blood 
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in such cases will be more effective in preventing reac-
tions and correcting the anemia. This theory can also 
be used to explain occasional severe he:nolytic reactions 
in post-partum patients. 
The Rh Factor and Group 0 
The use of group 0 as universal donor was first 
suggested by Ottenberg in 1911. (48) He showed at 
that time that incompatible agglutinogens in the donors 
blood usually caused a hemolytic reaction, but that 
atypical agglutinins caused little or no change. He 
explained this by the theory that probably the foreign 
agglutinins were diluted upon entering the patient's blood, 
and were not in sufficient concentration to cause a 
reaction. 
In 1923 Levine and Mabee (36) warned that indis-
criminant use of group O as donorE should be avoided 
because their titer of agg1ut1nins or hemolysins 
might be .exceptionally high, and in that way may pro-
duce a hemolysis of the donor's blood. 
Wiener (5S) showed that such reactions are not 
lbrays explained in this way. He demonstrated , in 
some cases, that in such transfusions hemolys1s of 
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of the donors (Rh positive ) blood was due to the Rh 
iso-Hntibodies in the patient's serum. Consequently, 
he suggested that a person of group 0. with Rh negative 
blood and weak iso-agglutinins in his serum, would be 
a 11 safe" universal donor except in those very rRre in-
stances where hemolysi- o curs in a patient of sub-
group A1B or A1 , when the rPcipients serum contains 
natural or immunizational anti-0 iso-antibodies. 
Heredity of the Rh Factor 
Landsteiner and Wiener, in 1941 (27), studied the 
heredity of the Rh factor in sixty families with '.?37 
children. In analogy to the other human blood proper-
ties, they presumed, by their studies, that Rh is trans-
mitted by a pair of genes, Rh and rh, a domi~ant and a 
recessive. Examination of these families showed that 
the agglutinogen was inherited as a simple mendelian 
dominant which is not sex-lir:ked. They also found that 
the Rh factor has a higher incidence among negroes. 
They suggested that further studies be m-::,de to 
prove that the Rh factor is not linked to A, B, M, N, 
or P in its heredity, as they surmised. If this is true, 
the property Rh may serve to mark a new pair of 
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chromosomes for linkage studies. 
Wiener and Peters (67) reported the frequency distrib-
ution of the agglutinogen Rh in the general population 
as 85% Rh positive and 15% RS Rh neg··tive. 
Determination of the Rh Factor 
The term n._ .. arm 11 agglutinin has been avplied to 
the Rh agglutinins because it was observed that they re-
act fe.r better at 3?°C, body temperature, than at 
lower temperature. In this respect they differ from 
other atypical agglutinins. Because of this reason, 
Levine recommended ~30) in cross-matching that the 
patient's serum and donors cells be incubated for at 
least 30 min~tes at 37°C, then centrifuged at a slow 
speed (500 r.p.m.) for one minute. 
Since there is not as yet an available source of 
anti-Rh agglutinins obtainable for the selection of Rh 
neg~tive donors, this method is considered adeluate for 
typing. 'Much ce.n be done to prevent intra-group reactions 
in mothers with its forty to fifty per cent mortality. 
It is believed thB.t almost all, if not all of these 
rea.ctions can be prevented by this method. Should the 
mother of a possible erythroblastosis bi::by require a 
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transfusion, it is much safer to find, first of all, 
her Rh status ti.nd find a compatible donor. (9) 
Landsteiner and Wiener ( ·:i7) have also suggested a 
method for the determinatio1 of the presence or absence 
or the Rh fA_ctor, which can be used for typing patients 
and prospective blood donors Tbis method is to absorb 
the sera, diluted one to four, with a quantity of blood 
(A or B cells if indicated) suffi~ient to remove the 
reaction with Rh negative blood. Then two drops of the 
test fluid ere mixed with one dro_p of 2% (in terms of 
blood sediment) washed blood suspersion, freshly prepared 
in a narrow tube of ? mm. diameter and allowed to stand 
e.t room temperature for thirty minutes to one hour. 
Inspection of the bottom of the tube with a hand 
lens shows negative reqcting bloods exhibiting a circular 
deposit with a smooth edge, while positive reacting bloods 
ha.ve sediment with a wrinkled or a serrated border or 
else show a granular deposit. 
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SUMMARY AND CONCLUSIONS 
The uncommon antigens and their corresponding 
agglutinins were discussed. The uncommon antigens dis-
cussed were: 1) The subgroups of groups A and AB; 2) The 
subgroups of group B; 3) Agglutinogens M, N, MN, P, Q., 
H, E, e, Rh, and others which are, as yet, unnamed; 
4) Extra agglutinin, 1. 
In view of the discussion presented, it is safe to 
disregard the subgroups of A and AB when selecting donors, 
except in those rare CRses when agglutinins n1 or A0 are 
found. In order to ascribe transfusion reactions to 
the subgroups, it is necessary to show that the donor and 
patient belo~g to different subgroups, and that the 
patient's serum contains &1 or a2 agglutinins. The 
dangers of reaction by the subgroups is not limited to 
incompatibilities, but also failures to recognize the 
subgroups, A2 . Methods of cro~s-matching are given, 
which will detect the subgroups. The subgroups are 
inherited, according to Mendel's Laws, allelornorphic 
genes, A1 , A2 , Band R, with genes A1 ,Ai;::i,P.nd B domin-
ant over R, and A1 dominant over A2 • 
The agglutinogens M, N, and Pare characterized 
oy their lack of antigenicity. Not a single transfusion 
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reaction can be traced to types M and N despite the 
hundreds of thousand.s of transfusions that have been 
given. However, among thousands of people tested, only 
three he.ve been found with natural anti-M iso-agglutinins, 
none hnve been found with anti N iso-agglutinins. 
According to the theory of 12.ndsteiner And Levine 
(20) the properties M and N are inherited as mendelian 
dominants. Their heredity depends upon a single pair 
of allelomorphic genes. 
It is noted that agglutinogen M is found more 
in negroes than in whites. 
As for the agglutinogen P, only one case is known 
where p antibodies have been formed in a human being 
after injection of blood containing agglutinogen P. It 
is inherited as a mendelian dominant nnd is not sex-
linked. 
It can be said of the other properties discussed that 
in general, the role played in transfusions is that they 
show marked difference as to their significance. As 
yet, m"ost of them have not reached the stage whe"·e 
practical ap~>l ica ti on is possible. (subgroups of group B) 
In other instances, their pract:cal importance lies in 
the fact that, because of their properties, they might 
easily be missed, leading to errors in typing blood. 
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All the cases reported in the literature of intra-
group reactions fall into two cat0gories: 1) Patients 
given repeated transfusions, the e~rliAr trRnsfusions 
serving to immunize them against the Rh antigen, and 
later transfusions giving rise to hemolytic reactions; 
2) Patients having reacti0ns following one transfusion; 
every instance of this group occurred. in i tra or post 
partum patients, the s~urce of the antigen h ving been 
the fetus in utero. 
Other conclusions show that erythroblastosis fetali s 
is the result of: 1) Isa-immunization of an Rh negi:1tive 
mother by the Rh blood of the fetus,and 2)the subsequent 
passage of the mother's agglutinin through the placenta 
to act on the susce~)tible blood of the fetus. 
The Rh factor has been ehonm to be inherited as a 
mendelian dominant and has been found to occur in 85% 
of the population. 
Recently, 1iliener (58) reported that reactions given 
by Rh sera demonstrates the existence of more than one 
sort of agglutinogen Rh, somewhat like the varieties 
of agglutinogen A. 
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